Keros Therapeutics (KROS)'s 30-day implied volatility (IV30) was 52.2% at the close on November 6, 2026, up from 49.6% the day before, against a 52-week range of 34.0% to 81.8%. Its 20-day historical volatility was 51.9%.
Data as of November 6, 2026.